November 21, 2017 5:30 PM ET

Biotechnology

Company Overview of Oncorus, Inc.

Company Overview

Oncorus, Inc. is a biotechnology company that develops immunotherapy platform to treat cancer. The company is based in Cambridge, Massachusetts.

Kendall Square

Cambridge, MA 02139

United States

Key Executives for Oncorus, Inc.

Chief Executive Officer
Age: 58
President and Chief Business Officer
Age: 42
Senior VP of Finance & Operations and Treasurer
Age: 37
Chief Scientific Officer & Senior VP of Research
Vice President of Chemistry, Manufacturing & Controls
Compensation as of Fiscal Year 2017.

Oncorus, Inc. Key Developments

Oncorus, Inc., Announces Management Changes

Oncorus, Inc. announced that the appointment of Christophe Quéva, as Chief Scientific Officer and Senior Vice President, Research. The company also announced the addition of Eric M. Sullivan as Senior Vice President, Finance & Operations and Treasurer, and Michael Paglia as Vice President, Chemistry, Manufacturing and Controls. Prior to joining the company, Christophe was Chief Scientific Officer at iTeos Therapeutics. As the company's Senior Vice President, Finance & Operations and Treasurer, Eric is responsible for finance and accounting, administration and corporate operations. Prior to joining the company, Eric was at bluebird bio, Inc. As Vice President, Chemistry, Manufacturing and Controls, Michael leads the company's process development, manufacturing, analytical sciences and quality control operations. Previously, he was at bluebird bio.

Oncorus, Inc. Presents at Cambridge Healthtech Institute's 5th Annual Immuno-Oncology Summit, Aug-28-2017 09:00 AM

Oncorus, Inc. Presents at Cambridge Healthtech Institute's 5th Annual Immuno-Oncology Summit, Aug-28-2017 09:00 AM. Venue: Sheraton Boston Hotel, 39 Dalton Street, Boston, Massachusetts, United States. Speakers: Paola Grandi, Senior Research Director, Immunology/Virology.

Oncorus Appoints Cyrus D. Mozayeni as President and Chief Business Officer

Oncorus has appointed Cyrus D. Mozayeni, M.D., as President and Chief Business Officer. Dr. Mozayeni will provide strategic leadership for the company, as well as have responsibility for corporate development, finance, legal, human resources and business operations. Dr. Mozayeni will report to Mitchell H. Finer, Ph.D., the company's Chief Executive Officer and Chief Scientific Officer. Prior to joining the company, Dr. Mozayeni served as Vice President and global head of business development and alliance management at bluebird bio.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3Bar Biologics Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
NYC2012, Inc. United States
Tax Management Inc United States
John F. Kennedy Center For The Performing Arts United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Oncorus, Inc., please visit www.oncorus.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.